364 related articles for article (PubMed ID: 23684663)
1. Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.
Zhang YP; Song CY; Yuan Y; Eber A; Rodriguez Y; Levitt RC; Takacs P; Yang Z; Goldberg R; Candiotti KA
Neurobiol Dis; 2013 Oct; 58():169-78. PubMed ID: 23684663
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.
Zhang YP; Eber A; Yuan Y; Yang Z; Rodriguez Y; Levitt RC; Takacs P; Candiotti KA
Anesthesiology; 2013 Apr; 118(4):945-54. PubMed ID: 23334664
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a rat model of type II diabetic neuropathic pain.
Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ
Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
[TBL] [Abstract][Full Text] [Related]
5. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation.
Suzuki S; Hinokio Y; Ohtomo M; Hirai M; Hirai A; Chiba M; Kasuga S; Satoh Y; Akai H; Toyota T
Diabetologia; 1998 May; 41(5):584-8. PubMed ID: 9628277
[TBL] [Abstract][Full Text] [Related]
6. Effect of Coenzyme Q10 on Oxidative Stress, Glycemic Control and Inflammation in Diabetic Neuropathy: A Double Blind Randomized Clinical Trial.
Akbari Fakhrabadi M; Zeinali Ghotrom A; Mozaffari-Khosravi H; Hadi Nodoushan H; Nadjarzadeh A
Int J Vitam Nutr Res; 2014; 84(5-6):252-60. PubMed ID: 26255546
[TBL] [Abstract][Full Text] [Related]
7. P2Y12 shRNA treatment decreases SGC activation to relieve diabetic neuropathic pain in type 2 diabetes mellitus rats.
Wang S; Wang Z; Li L; Zou L; Gong Y; Jia T; Zhao S; Yuan H; Shi L; Liu S; Wu B; Yi Z; Liu H; Gao Y; Li G; Deussing JM; Li M; Zhang C; Liang S
J Cell Physiol; 2018 Dec; 233(12):9620-9628. PubMed ID: 29943819
[TBL] [Abstract][Full Text] [Related]
8. Alpha-lipoic acid and coenzyme Q10 combination ameliorates experimental diabetic neuropathy by modulating oxidative stress and apoptosis.
Sadeghiyan Galeshkalami N; Abdollahi M; Najafi R; Baeeri M; Jamshidzade A; Falak R; Davoodzadeh Gholami M; Hassanzadeh G; Mokhtari T; Hassani S; Rahimifard M; Hosseini A
Life Sci; 2019 Jan; 216():101-110. PubMed ID: 30393023
[TBL] [Abstract][Full Text] [Related]
9. Alterations of erythrocyte free radical defense system, heart tissue lipid peroxidation, and lipid concentration in streptozotocin-induced diabetic rats under coenzyme Q10 supplementation.
Al-Thakafy HS; Khoja SM; Al-Marzouki ZM; Zailaie MZ; Al-Marzouki KM
Saudi Med J; 2004 Dec; 25(12):1824-30. PubMed ID: 15711648
[TBL] [Abstract][Full Text] [Related]
10. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats.
Modi K; Santani DD; Goyal RK; Bhatt PA
Biol Trace Elem Res; 2006 Jan; 109(1):25-34. PubMed ID: 16388100
[TBL] [Abstract][Full Text] [Related]
11. The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats.
Xu X; Liu Z; Liu H; Yang X; Li Z
Eur J Pharmacol; 2012 Apr; 680(1-3):28-33. PubMed ID: 22306246
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice.
Sohet FM; Neyrinck AM; Pachikian BD; de Backer FC; Bindels LB; Niklowitz P; Menke T; Cani PD; Delzenne NM
Biochem Pharmacol; 2009 Dec; 78(11):1391-400. PubMed ID: 19632207
[TBL] [Abstract][Full Text] [Related]
13. Acute Hypoglycemia Induces Painful Neuropathy and the Treatment of Coenzyme Q10.
Zhang YP; Mei S; Yang J; Rodriguez Y; Candiotti KA
J Diabetes Res; 2016; 2016():4593052. PubMed ID: 26824041
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation.
Suzuki N; Hasegawa-Moriyama M; Takahashi Y; Kamikubo Y; Sakurai T; Inada E
Anesth Analg; 2011 Oct; 113(4):941-6. PubMed ID: 21788310
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model.
Shi TJ; Zhang MD; Zeberg H; Nilsson J; Grünler J; Liu SX; Xiang Q; Persson J; Fried KJ; Catrina SB; Watanabe M; Arhem P; Brismar K; Hökfelt TG
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):690-5. PubMed ID: 23267110
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats.
Sun Q; Zhang BY; Zhang PA; Hu J; Zhang HH; Xu GY
Mol Pain; 2019; 15():1744806919838659. PubMed ID: 30838902
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia.
Liu S; Zou L; Xie J; Xie W; Wen S; Xie Q; Gao Y; Li G; Zhang C; Xu C; Xu H; Wu B; Lv Q; Zhang X; Wang S; Xue Y; Liang S
Mol Brain; 2016 Apr; 9():44. PubMed ID: 27107575
[TBL] [Abstract][Full Text] [Related]
18. Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes.
Liao YH; Zhang GH; Jia D; Wang P; Qian NS; He F; Zeng XT; He Y; Yang YL; Cao DY; Zhang Y; Wang DS; Tao KS; Gao CJ; Dou KF
Brain Res; 2011 Jan; 1368():324-35. PubMed ID: 20971097
[TBL] [Abstract][Full Text] [Related]
19. Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.
Katz NK; Ryals JM; Wright DE
Neuroscience; 2015 Jan; 285():312-23. PubMed ID: 25451280
[TBL] [Abstract][Full Text] [Related]
20. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
Pabreja K; Dua K; Sharma S; Padi SS; Kulkarni SK
Eur J Pharmacol; 2011 Jul; 661(1-3):15-21. PubMed ID: 21536024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
